CLINICAL_TRIALS
trial_result
· 2018-08-03
Clinical Trial Update: Feru-guard for Behavioral Symptoms in Dementia [Phase 2]
Summary
Phase 2 trial update for Feru-guard targeting behavioral and psychiatric symptoms in dementia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Glovia Co., Ltd. | Conditions: Behavioral and Psychiatric Symptoms of Dementia | Phase 2 | Status: UNKNOWN